Skip to main content
. 2021 Oct 29;10(21):5074. doi: 10.3390/jcm10215074

Table 6.

The influence of Firmicutes/Bacteroidetes ratio on targeted metabolomics (Biocrates) and biochemical test adjusted for age, sex, CAD status, statins treatment (and) LDL cholesterol concentration.

Metabolite or Biochemical Test Group with F/B Ratio ≤ 1.54
(n = 167)
Group with F/B Ratio > 1.54
(n = 167)
p Value
Phosphatidylcholine with diacyl residue sum C36:4, μmol/L 145,308.5375
(95% CI 136,165.244–154,451.831)
131,525.3521
(95% CI 122,485.2512–140,565.4529)
0.037 *
Phosphatidylcholine with diacyl residue sum C38:5, μmol/L 46,853.2875
(95% CI 43,791.1361–49,915.4389)
41,838.3521
(95% CI 39,090.319–44,586.3852)
0.019 *
Phosphatidylcholine with diacyl residue sum C38:6, μmol/L 68,122.05
(95% CI 62,784.975–73,459.125)
58,899.7887
(95% CI 54,099.1744–63,700.403)
0.013 *
Phosphatidylcholine with diacyl residue sum C40:6, μmol/L 26,837.9747
(95% CI 24,778.9683–28,896.9811)
23,893.6056
(95% CI 21,873.7272–25,913.484)
0.047 *
Phosphatidylcholine with acyl-alkyl residue sum C30:0, μmol/L 165.6974
(95% CI 153.7441–177.6507)
209.942
(95% CI 178.6529–241.2311)
0.008 *
Phosphatidylcholine with acyl-alkyl residue sum C34:0, μmol/L 839.25
(95% CI 782.9649–895.5351)
958.2254
(95% CI 852.6987–1063.7521)
0.045 *
Phosphatidylcholine with acyl-alkyl residue sum C38:0, μmol/L 1663.75
(95% CI 1520.5806–1806.9194)
1465.4225
(95% CI 1353.087–1577.758)
0.034 *
Sphingomyelin with acyl residue sum C24:1, μmol/L 69,876.9375
(95% CI 65,633.3358–74,120.5392)
63,321.1268
(95% CI 59,226.511–67,415.7426)
0.028 *
Hematocrit, % 41.3928
(95% CI 40.8434–41.9422)
41.8814
(95% CI 41.3236–42.4392)
0.047 *
Hemoglobin, g/dL 14.1371
(95% CI 13.9429–14.3313)
14.3413
(95% CI 14.1502–14.5324)
0.023 *
Total cholesterol, mg/dL 188.9341
(95% CI 181.2163–196.6519)
171.2455
(95% CI 164.3927–178.0983)
0.006 **
LDL cholesterol, mg/dL 118.8796
(95% CI 112.3616–125.3976)
104.9257
(95% CI 98.4497–111.4017)
0.026 **

CI—confidence interval. Mean values together with the 95% confidence intervals of the means are presented. (* Adjusted for Age, Sex, CAD Status, LDL Cholesterol Concentration, Statins Treatment; ** Adjusted for Age, Sex, CAD Status, Statins Treatment).